Serial Number 98811281
688

Registration Progress

Application Filed
Oct 21, 2024
Under Examination
Oct 14, 2025
Approved for Publication
Aug 19, 2025
Published for Opposition
Aug 19, 2025
Registered

Attorney Assistance

NOA E-Mailed - SOU Required
Due: Apr 14, 2026 98 days

Trademark Image

Basic Information

Serial Number
98811281
Filing Date
October 21, 2024
Published for Opposition
August 19, 2025
Drawing Code
2

Status Summary

Current Status
Active
Status Code
688
Status Date
Oct 14, 2025
Application
Pending
Classes
005

Rights Holder

Astellas Pharma Inc.

03
Address
5-1, Nihonbashi-Honcho 2-chome, Chuo-ku
Tokyo 103-8411
JP

Ownership History

Astellas Pharma Inc.

Original Applicant
03
Tokyo JP

Astellas Pharma Inc.

Owner at Publication
03
Tokyo JP

Legal Representation

Attorney
Christopher Bolinger

USPTO Deadlines

Next Deadline
98 days remaining
NOA E-Mailed - SOU Required
Due Date
April 14, 2026
Extension Available
Until October 14, 2026

Application History

29 events
Date Code Type Description Documents
Oct 14, 2025 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Aug 19, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Aug 19, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Aug 13, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jul 11, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jul 11, 2025 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Jul 11, 2025 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Jul 11, 2025 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Jul 11, 2025 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Jul 10, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jul 10, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jul 10, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
May 20, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
May 20, 2025 ECDR I TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Loading...
May 20, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
May 20, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
May 20, 2025 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
May 20, 2025 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
May 6, 2025 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
May 6, 2025 GNRT F NON-FINAL ACTION E-MAILED Loading...
May 6, 2025 CNRT R NON-FINAL ACTION WRITTEN Loading...
May 6, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
May 5, 2025 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
May 5, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 14, 2025 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Apr 14, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Apr 14, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Apr 14, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Oct 21, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for intraoperative ureter and lymph node visualization for use during surgical and medical procedures; diagnostic agents, preparations, and substances for medical purposes; contrast media for in vivo imaging; contrast media for use with imaging medical equipment

Additional Information

Design Mark
The mark consists of four square shapes that are each made up of four rows of circular dots. These four rows of dots transition in color from light green, to green, to blue.
Color Claim
The color(s) The colors blue, green, and light green is/are claimed as a feature of the mark.

Classification

International Classes
005